Cases & Deals

  • Home
  • Practices
  • InSite Vision monetizes patent-related royalty stream

Share

InSite Vision monetizes patent-related royalty stream

April 2013

Client(s) InSite Vision Incorporated

Jones Day advised InSite Vision Incorporated, a developer of novel ophthalmic products designed to treat a growing range of common eye problems, in connection with the monetization of a patent-related royalty stream from future sales of Besivance® (besifloxacin opthalmic suspension), which is marketed globally by Bausch & Lomb for the treatment of bacterial conjunctivitis.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.